CDD will be at the American Chemical Society Fall 2010 meeting from Aug 22-26 at the Boston Convention & Exposition Center. Dr. Sean Ekins will be giving two talks:
“Collaborative Drug Discovery: A Platform for transforming neglected disease R&D and beyond”
DIVISION: BMGT: Division of Business Development and Management
SESSION: Open-Source Drug Discovery
SESSION START TIME: August 23, 2010, 1:30 pm
DAY & TIME OF PRESENTATION: August 23, 2010 3:35 pm
LOCATION: Room 254 A/B
ACS Open-Source Drug Discovery Symposium Program
“Collaborative Database And Computational Models For Tuberculosis Drug Discovery Decision Making”
DIVISION: CINF: Division of Chemical Information
SESSION: Data-intensive Drug Design
SESSION START TIME: August 22, 2010, 1:45 pm
DAY & TIME OF PRESENTATION: August 22, 2010 3:45 pm
LOCATION: Room 156A
Dr. Ekins will also present two posters:
“Essential Metabolites of M. tuberculosis and their Molecular Mimics”
DIVISION: BIOL: Division of Biological Chemistry
SESSION: Advances in Biological Chemistry
SESSION START TIME: August 24, 2010, 5:30 pm
LOCATION: Hall C
“Using Open Source Descriptors and Algorithms for Modeling ADME Properties.”
DIVISION: MEDI: Division of Medicinal Chemistry
SESSION: General Poster Session
SESSION START TIME: August 25, 2010, 7:00 pm
LOCATION: Ballroom
The latter poster was in collaboration with Pfizer. Please feel free to drop by the posters or attend the talks and say hello. We will be happy to answer any questions on the work presented or CDD. All posters and posters will be available on the website after the meeting.
We invite you to submit your poster presentation and register to attend the 4th Annual CDD Community Meeting, a 1-day event on October 21st. The CDD Community Meeting is the best place for the CDD community and all scientists to get together, discuss their research projects, and showcase their work to others in the community.
Confirmed Speakers:
- G. Steven Burrill, CEO, Burrill & Company: Life Sciences Venture Capital, Private Equity, Merchant Banking, and Media
- Ricardo Macarrón, EMTM, PhD, VP of Sample Management Technologies – PTS, GlaxoSmithKline
- Richard Elliott, PhD, Senior Program Officer, Bill & Melinda Gates Foundation (B&MGF)
- Clifton Barry, PhD, Senior Investigator & Chief, Tuberculosis Research Section, NIAID (NIH)
- Phil Skolnick, PhD, DSc (hon.), Director, Division of Pharmacotherapies & Medical Consequences of Drug Abuse, National Institute on Drug Abuse (NIDA)
- Sorena Nadaf, Director of Translational Bioinformatics & CIO, UCSF Helen Diller Family Comprehensive Cancer Center
- Jonathan Baell, PhD, Medicinal Chemistry Group Leader, Walter and Eliza Hall Institute of Medical Research (Australia)
- Michael Pollastri, PhD, Associate Professor, Chemistry and Chemical Biology, Northeastern University
- Plus other leading Industry, Academic, Foundation, and Govt scientists (please contact info@collaborativedrug.com if you have a proposal for talk, poster, etc)
For directions to/parking at the UCSF Mission Bay Conference Center, please click here:
There are many hotel options in downtown SF; we recommend the Courtyard Mariott as a good value.
Click here to register now!
CDD will be at the Chem Outsourcing Meeting at the Ocean Place Resort in Long Branch, NJ from September 14-16.
Kellan Gregory will be on a panel in Track C entitled “Sharing Data Securely & Efficiently in Collaborations with CROs” on Thursday September 16 at 1:15 PM.
CDD will be present at the Medicines for Neglected Disease Workshop, to be held at Boston University from September 10-11.
Barry Bunin, PhD, will be speaking on applying the CDD Platform to accelerate Neglected Disease R&D.
CDD will be presenting at the Collaborative Innovation in Biomedicine Conference on June 14-16 at the Sheraton Philadelphia City Center Hotel in Philadelphia.
Sean Ekins of CDD will be giving a talk entitled “Reaching Out to Collaborators on the Cloud: Crowd-Sourcing for Pharmaceutical Research”
CDD will be at the 3rd Conference on the Systems Biology of Mammalian Cells (SBMC) at the Konzerthaus in Freiburg, Germany.
Sean Ekins, PhD will be giving a presentation entitled “Toxicity Pathways and Models: Mining for potential off-target effects.”
CDD will be presenting at BioConference Live, an online-only conference on June 2-3.
Barry Bunin, PhD, will give a talk entitled “Collaborative Drug Discovery Humanitarian and Commercial Researcher Network Case Studies.” Stay tuned for more details!
CDD will be at QSAR 2010 – 14th International Workshop on Quantitative Structure-Activity Relationships (QSARs) in Environmental and Health Sciences. The meeting will take place on May 24-28 at the Hilton Montréal Bonaventure, in Montréal, Canada.
Sean Ekins, PhD, will be giving a presentation entitled “QSAR and Systems biology for toxicity assessment: back to the future.”
CDD will be presenting at the MIT Innovation Lab Meeting at the Google Campus in Mountain View on May 24-25.
CDD CEO Barry Bunin, PhD, and CDD Board Director Alpheus Bingham, PhD will be giving a talk on the pharmaceutial industry ecology and CDD’s novel methods and results in producing open innovation in this space.
CDD will be presenting at the 2010 Accelrys User Group Meeting, taking place from May 4 to May 6 in Boston, MA, at the Westin Waterfront Hotel.
CDD’s own Sean Ekins, PhD will be giving a talk entitled “A Collaborative Database And Computational Models For Tuberculosis Drug Discovery.”
